サマリー

血漿治療薬の世界市場2022-2026年
Technavioは血漿治療薬市場を監視しており、2022-2026年の間に89億8000万ドルの成長が見込まれ、予測期間中にCAGR6.1％で進行しています。当レポートでは、血漿治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、中国におけるアルブミンの高い需要、外科手術の増加、統治機関による新たな承認によって牽引されています。
血漿治療薬市場の分析には、製品セグメントと地理的展望が含まれます。
Technavioの血漿治療薬市場は、以下のように区分されています。
製品別
- 免疫グロブリン
- アルブミン
- 血液因子
- その他
地域別構成比
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、グローバル企業による発展途上国での血漿分画施設の設立が、今後数年間の血漿治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、市場の成長を促進するベンダーの戦略的イニシアティブと、早期診断の重要性に対する意識の高まりは、市場の大きな需要につながるでしょう。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。血漿治療薬市場に関する当レポートは、以下の分野を対象としています。
- 血漿治療薬市場のサイジング
- 血漿治療薬市場の予測
- 血漿治療薬市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されており、これに沿って本レポートでは、ADMA Biologics Inc、Bio Products Laboratory Ltd、BIOPHARMA PLASMA、CSL Ltd、Emergent BioSolutions Inc、Evolve Biologics Inc、Grifols SA、Kamada Ltd、Kedrion Spa、Octapharma AG、Pfizer Inc、Prothya Biosolutions Netherlands BV、SK Discovery Co.Ltd.、武田薬品工業(株)Ltd.、Prothya Biosutions Netherlands BV、SK Discovery Co.また、血漿治療薬市場の分析レポートには、今後の動向と市場成長に影響を与える課題に関する情報も含まれています。これは、企業が戦略を立て、今後訪れるすべての成長機会を活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/plasma-therapeutics-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Product
o 5.1 Market segments
o Exhibit 24: Chart on Product - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
o 5.2 Comparison by Product
o Exhibit 26: Chart on Comparison by Product
o Exhibit 27: Data Table on Comparison by Product
o 5.3 Immunoglobulin - Market size and forecast 2021-2026
o Exhibit 28: Chart on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Immunoglobulin - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Immunoglobulin - Year-over-year growth 2021-2026 (%)
o 5.4 Albumin - Market size and forecast 2021-2026
o Exhibit 32: Chart on Albumin - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Albumin - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Albumin - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Albumin - Year-over-year growth 2021-2026 (%)
o 5.5 Blood factors - Market size and forecast 2021-2026
o Exhibit 36: Chart on Blood factors - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Blood factors - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Blood factors - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Blood factors - Year-over-year growth 2021-2026 (%)
o 5.6 Others - Market size and forecast 2021-2026
o Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.7 Market opportunity by Product
o Exhibit 44: Market opportunity by Product ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 48: Chart on Geographic comparison
o Exhibit 49: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.10 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.11 China - Market size and forecast 2021-2026
o Exhibit 82: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 83: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 84: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 85: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 86: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 87: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 89: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 90: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 91: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 92: Matrix on vendor position and classification
o 10.3 ADMA Biologics Inc.
o Exhibit 93: ADMA Biologics Inc. - Overview
o Exhibit 94: ADMA Biologics Inc. - Business segments
o Exhibit 95: ADMA Biologics Inc. - Key offerings
o Exhibit 96: ADMA Biologics Inc. - Segment focus
o 10.4 Bio Products Laboratory Ltd.
o Exhibit 97: Bio Products Laboratory Ltd. - Overview
o Exhibit 98: Bio Products Laboratory Ltd. - Product / Service
o Exhibit 99: Bio Products Laboratory Ltd. - Key offerings
o 10.5 CSL Ltd.
o Exhibit 100: CSL Ltd. - Overview
o Exhibit 101: CSL Ltd. - Business segments
o Exhibit 102: CSL Ltd. - Key news
o Exhibit 103: CSL Ltd. - Key offerings
o Exhibit 104: CSL Ltd. - Segment focus
o 10.6 Grifols SA
o Exhibit 105: Grifols SA - Overview
o Exhibit 106: Grifols SA - Business segments
o Exhibit 107: Grifols SA - Key offerings
o Exhibit 108: Grifols SA - Segment focus
o 10.7 Kamada Ltd.
o Exhibit 109: Kamada Ltd. - Overview
o Exhibit 110: Kamada Ltd. - Product / Service
o Exhibit 111: Kamada Ltd. - Key offerings
o 10.8 Kedrion Spa
o Exhibit 112: Kedrion Spa - Overview
o Exhibit 113: Kedrion Spa - Product / Service
o Exhibit 114: Kedrion Spa - Key offerings
o 10.9 Octapharma AG
o Exhibit 115: Octapharma AG - Overview
o Exhibit 116: Octapharma AG - Product / Service
o Exhibit 117: Octapharma AG - Key offerings
o 10.10 Prothya Biosolutions Netherlands BV
o Exhibit 118: Prothya Biosolutions Netherlands BV - Overview
o Exhibit 119: Prothya Biosolutions Netherlands BV - Product / Service
o Exhibit 120: Prothya Biosolutions Netherlands BV - Key offerings
o 10.11 SK Discovery Co. Ltd.
o Exhibit 121: SK Discovery Co. Ltd. - Overview
o Exhibit 122: SK Discovery Co. Ltd. - Product / Service
o Exhibit 123: SK Discovery Co. Ltd. - Key offerings
o 10.12 Takeda Pharmaceutical Co. Ltd.
o Exhibit 124: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 125: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 126: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 127: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 128: Inclusions checklist
o Exhibit 129: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 130: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 131: Research methodology
o Exhibit 132: Validation techniques employed for market sizing
o Exhibit 133: Information sources
o 11.5 List of abbreviations
o Exhibit 134: List of abbreviations

Exhibits
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Product - Market share 2021-2026 (%)
Exhibits25: Data Table on Product - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Product
Exhibits27: Data Table on Comparison by Product
Exhibits28: Chart on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Immunoglobulin - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Immunoglobulin - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Immunoglobulin - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Albumin - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Albumin - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Albumin - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Albumin - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Blood factors - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Blood factors - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Blood factors - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Blood factors - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Product ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: ADMA Biologics Inc. - Overview
Exhibits94: ADMA Biologics Inc. - Business segments
Exhibits95: ADMA Biologics Inc. - Key offerings
Exhibits96: ADMA Biologics Inc. - Segment focus
Exhibits97: Bio Products Laboratory Ltd. - Overview
Exhibits98: Bio Products Laboratory Ltd. - Product / Service
Exhibits99: Bio Products Laboratory Ltd. - Key offerings
Exhibits100: CSL Ltd. - Overview
Exhibits101: CSL Ltd. - Business segments
Exhibits102: CSL Ltd. - Key news
Exhibits103: CSL Ltd. - Key offerings
Exhibits104: CSL Ltd. - Segment focus
Exhibits105: Grifols SA - Overview
Exhibits106: Grifols SA - Business segments
Exhibits107: Grifols SA - Key offerings
Exhibits108: Grifols SA - Segment focus
Exhibits109: Kamada Ltd. - Overview
Exhibits110: Kamada Ltd. - Product / Service
Exhibits111: Kamada Ltd. - Key offerings
Exhibits112: Kedrion Spa - Overview
Exhibits113: Kedrion Spa - Product / Service
Exhibits114: Kedrion Spa - Key offerings
Exhibits115: Octapharma AG - Overview
Exhibits116: Octapharma AG - Product / Service
Exhibits117: Octapharma AG - Key offerings
Exhibits118: Prothya Biosolutions Netherlands BV - Overview
Exhibits119: Prothya Biosolutions Netherlands BV - Product / Service
Exhibits120: Prothya Biosolutions Netherlands BV - Key offerings
Exhibits121: SK Discovery Co. Ltd. - Overview
Exhibits122: SK Discovery Co. Ltd. - Product / Service
Exhibits123: SK Discovery Co. Ltd. - Key offerings
Exhibits124: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits125: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits126: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits127: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits128: Inclusions checklist
Exhibits129: Exclusions checklist
Exhibits130: Currency conversion rates for US$
Exhibits131: Research methodology
Exhibits132: Validation techniques employed for market sizing
Exhibits133: Information sources
Exhibits134: List of abbreviations